Genesco Inc.

GCO · NYSE

$34.99▼ -3.29%

$1.19 today

Mkt cap $388.63M
P/E 18.9
Day $33.98 – $35.68

Confidence

High conviction

The read

Genesco shares rally 9.5% post-Q1 2027 earnings despite unavailable EPS data

Genesco's stock surged 9.5% following Q1 2027 results with 3% revenue growth driven by Journeys' 5% comps and 21 new stores, offset by Schuh's 9% sales decline. EPS was not reported. Valuation remains attractive with forward P/E 27% below sector. Investors await June 3 earnings and guidance for growth clarity.

Confidence note: Analysis based on strong price reaction and detailed segment sales data; limited by unavailable EPS and explicit guidance.

What happened

Earnings print

EPS data unavailable; consensus estimate was -2.55 for Q1 2027.

Guidance

No explicit guidance disclosed; market reaction suggests positive sentiment toward growth prospects.

Price reaction

Shares rose 9.48% on earnings day, closing at $42.72, reflecting strong investor enthusiasm.

Street narrative

Revenue grew 3% led by Journeys' 5% comparable sales and 21 new stores; Schuh sales declined 9% due to fewer promotions. Operating margin and ROE remain weak at 1.1% and 3.7%, respectively. Institutional ownership is high at 88.9%, and valuation metrics indicate a discount to sector averages.

So what

What changed

Stock price increased 9.5% after Q1 revenue growth of 3% despite missing EPS data.

What the market is pricing

Market is pricing optimism on Journeys' growth and attractive valuation despite profitability concerns.

Fundamental takeaway

Maintain a constructive bias; monitor upcoming guidance and margin trends for confirmation.

Next 30–90 days

Bull

39%

Sustained revenue growth and margin improvement drive EPS above consensus, lifting shares.

June 3 earnings guidance confirms margin expansion
Continued comparable sales growth at Journeys

Base

36%

Revenue growth continues modestly with stable margins; shares trade sideways to modestly higher.

Guidance aligns with current estimates
Journeys maintains steady comps

Bear

25%

Profitability challenges persist with declining sales and weak margins, pressuring shares.

Guidance cut on revenue or margins
Continued Schuh sales decline

What to do

If you hold it

Hold shares unless June 3 guidance signals margin contraction or sales weakness.

If you're watching

Add if post-earnings guidance confirms margin improvement and sustained sales growth; avoid if guidance is negative or EPS misses consensus.

Keep on your radar

June 3 earnings and guidance release
Comparable sales trends at Journeys and Schuh brands
Operating margin and ROE changes in upcoming quarters
Institutional ownership shifts or insider activity